AstraZeneca, Novartis, rival drug makers to buy renewable energy from Envision for manufacturing plants in China
AstraZeneca, Novartis and some their global peers have agreed to buy renewable power for their manufacturing facilities in mainland China under a three-year supply deal with Envision Energy.
United States Tang Weimin Chen Dipeng World Wide Fund For Nature United Sustainable Markets Initiative World Health Organization
Source: scmp.com